Search research articles
Contact Us
Filters
Showing results (91-100 of 154) with videos related to
Page
of 16
Sort By:
Haematologica
|
July 10, 2009
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, et al.
Haematologica
|
July 2, 2013
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi
Annalisa Chiappella, Alessandra Tucci, Alessia Castellino, et al.
American Journal of Hematology
|
December 16, 2014
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma
Luca Arcaini, Lucia Morello, Alessandra Tucci, et al.
Annals of Hematology
|
November 21, 2020
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments
Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, et al.
Cancers
|
May 14, 2022
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment
Andrea Emanuele Guerini, Alessandra Tucci, Filippo Alongi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2010
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients
Pier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, et al.
British Journal of Haematology
|
November 30, 2010
Immunogenetics features and genomic lesions in splenic marginal zone lymphoma
Andrea Rinaldi, Francesco Forconi, Luca Arcaini, et al.
British Journal of Haematology
|
July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study
Vincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
British Journal of Haematology
|
January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)
Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2004
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma
Pier Luigi Zinzani, Alessandro Pulsoni, Alessio Perrotti, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 154) with videos related to
Sort By:
Page
of 16
Haematologica
|
July 10, 2009
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, et al.
Haematologica
|
July 2, 2013
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi
Annalisa Chiappella, Alessandra Tucci, Alessia Castellino, et al.
American Journal of Hematology
|
December 16, 2014
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma
Luca Arcaini, Lucia Morello, Alessandra Tucci, et al.
Annals of Hematology
|
November 21, 2020
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments
Alessia Bari, Raffaella Marcheselli, Stefano Sacchi, et al.
Cancers
|
May 14, 2022
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment
Andrea Emanuele Guerini, Alessandra Tucci, Filippo Alongi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2010
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients
Pier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, et al.
British Journal of Haematology
|
November 30, 2010
Immunogenetics features and genomic lesions in splenic marginal zone lymphoma
Andrea Rinaldi, Francesco Forconi, Luca Arcaini, et al.
British Journal of Haematology
|
July 30, 2022
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study
Vincenzo Marasco, Alfonso Piciocchi, Anna Candoni, et al.
British Journal of Haematology
|
January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)
Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2004
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma
Pier Luigi Zinzani, Alessandro Pulsoni, Alessio Perrotti, et al.
Page
of 16